FSMDX
Price
$35.65
Change
-$0.10 (-0.28%)
Updated
Aug 8 closing price
Net Assets
43.39B
KMVAX
Price
$37.75
Change
+$0.03 (+0.08%)
Updated
Aug 8 closing price
Net Assets
104.96M
Interact to see
Advertisement

FSMDX vs KMVAX

Header iconFSMDX vs KMVAX Comparison
Open Charts FSMDX vs KMVAXBanner chart's image
Fidelity Mid Cap Index
Price$35.65
Change-$0.10 (-0.28%)
VolumeN/A
Net Assets43.39B
Kirr Marbach Partners Value
Price$37.75
Change+$0.03 (+0.08%)
VolumeN/A
Net Assets104.96M
FSMDX vs KMVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMDX vs. KMVAX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and KMVAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 43.4B vs. KMVAX (105M). FSMDX pays higher dividends than KMVAX: FSMDX (1.29) vs KMVAX (0.00). FSMDX was incepted earlier than KMVAX: FSMDX (14 years) vs KMVAX (27 years). KMVAX (1.35) is less costly to investors than FSMDX (0.03). FSMDX is a more actively managed with annual turnover of: 15.00 vs. KMVAX (9.00). FSMDX has a lower initial minimum investment than KMVAX: FSMDX (0) vs KMVAX (1000). KMVAX annual gain was more profitable for investors over the last year : 21.46 vs. FSMDX (13.75). KMVAX return over 5 years is better than : 89.98 vs. FSMDX (64.86).
FSMDXKMVAXFSMDX / KMVAX
Total Expense Ratio0.031.352%
Annual Report Gross Expense Ratio0.031.352%
Fund Existence14 years27 years-
Gain YTD5.82316.90934%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets43.4B105M41,333%
Annual Yield % from dividends1.290.00-
Returns for 1 year13.7521.4664%
Returns for 3 years35.3951.3069%
Returns for 5 years64.8689.9872%
Returns for 10 years121.1361.74196%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICCC6.660.52
+8.47%
ImmuCell Corp
DYN11.19N/A
N/A
Dyne Therapeutics
CHSCN25.40-0.02
-0.08%
CHS
AXTA28.39-0.08
-0.28%
Axalta Coating Systems Ltd
LE12.96-0.42
-3.14%
Lands' End